Ethics of Human Genome Editing.

Area of Science:

• Bioethics
• Genetics
• Molecular Biology

Background:

• Advances in human genome editing technologies, such as CRISPR/Cas9, have intensified ethical debates.
• Concerns center on the implications of altering the human genome, particularly heritable changes.

Purpose of the Study:

• To review the ethical and regulatory landscape of human genome editing.
• To present recommendations from a multidisciplinary international committee on somatic and germline genome editing.

Main Methods:

• A multidisciplinary, international committee was convened by the US National Academies of Sciences and Medicine.
• The committee reviewed the current status of human genome editing and formulated recommendations.

Main Results:

• Recommended applying existing ethical and regulatory standards for gene therapy to somatic (nonheritable) human genome editing.
• Recommended allowing experimental germline (heritable) genome editing for serious disease prevention under stringent ethical and regulatory oversight.

Conclusions:

• Somatic genome editing should adhere to current gene therapy guidelines.
• Experimental germline genome editing may proceed cautiously for specific disease prevention, with rigorous ethical and regulatory controls.
• Significant bioethical issues, including potential impacts on individuals with disabilities, require careful consideration.